Will TherapeuticsMD’s Yuvvexy Pass The FDA Muster?

http://ift.tt/eA8V8J

TherapeuticsMD Inc (NYSE: TXMD) shares were down 44.4 percent in 2016.

read more

May 07, 2017 at 11:38PM

http://ift.tt/2qPM4vl

from Shanthi Rexaline

http://ift.tt/2qPM4vl